Viatris to sell India women health care, API businesses for $1.2 billion
US-based drugmaker Viatris, previously known as Mylan, is selling its active pharmaceutical ingredients (API) and women’s health care businesses in India for a combined consideration of $1.2 billion (nearly Rs 10,000 crore) as…